Results 21 to 30 of about 7,318,203 (396)
A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project. [PDF]
, 2020 Neurologists managing women with Multiple Sclerosis (MS) need information about the safety of disease modifying drugs (DMDs) during pregnancy. However, this knowledge is limited.
A Haghikia +20 more
core +1 more source
Pregnancy and multiple sclerosis [PDF]
Obstetric Medicine, 2012 The relapse rate of multiple sclerosis (MS) is typically reduced during late pregnancy but increases in the postpartum period. The reasons for the increased postpartum activity are not entirely clear, but factors such as the abrupt decrease in oestrogen levels immediately after the delivery and the loss of the immunosuppressive state of pregnancy are ...
Risto Kaaja, Laura Airas
openaire +7 more sources
The Epidemiology of Multiple Pregnancies [PDF]
Acta geneticae medicae et gemellologiae: twin research, 1994 AbstractOver the last decades the frequency of multiple births has been on the decline in most developed countries. This trend, however, has been restricted to dizygotic twins, while monozygotic rates have remained stable or risen slowly. In more recent years, however, the fall in multiple dizygotic birth rates has ceased and a slight increase is ...
F. Parazzini +4 more
openaire +4 more sources
Acta Biomedica Scientifica, 2022 Background. Multiple pregnancy is a well-established risk factor for preterm birth. Prevention of early termination of pregnancy is a priority problem in obstetric practice.The aim. To evaluate the role of an obstetric pessary and micronized progesterone
A. A. Belinina +4 more
doaj +1 more source
Pregnancy and multiple sclerosis. [PDF]
Journal of Neurology, Neurosurgery & Psychiatry, 1988 The effect of pregnancy on the relapse rate of multiple sclerosis has been investigated. Obstetric and relapse histories of 52 women with clinically definite multiple sclerosis were obtained; there were 101 pregnancies of which 85 were at risk of a multiple sclerosis relapse.
J A Frith, J. G. McLEOD
openaire +7 more sources
Pregnancy outcome following exposure to ocrelizumab in multiple sclerosis
Multiple sclerosis journal - experimental, translational and clinical, 2022 Background Ocrelizumab is a monoclonal antibody targeting CD20-expressing B cells used in the treatment of multiple sclerosis (MS). Currently, there is limited safety data in pregnancy.
Shin Yee Chey, A. Kermode
semanticscholar +1 more source
Treatment of Women with Multiple Sclerosis Planning Pregnancy
Current Treatment Options in Neurology, 2021 We review data available for treatment of multiple sclerosis (MS) before, during, and after pregnancy. We present recent data on disease-modifying therapies (DMT) before/during pregnancy and while breastfeeding, with treatment recommendations ...
K. Krysko +4 more
semanticscholar +1 more source
Revista Brasileira de Ginecologia e Obstetrícia, 2022 Objective It is known that the single embryo transfer (SET) is the best choice to reduce multiples and associated risks. The practice of cryopreserving all embryos for posterior transfer has been increasingly performed for in vitro fertilization (IVF ...
Pedro Felipe Magalhães Peregrino +6 more
doaj +1 more source
Women’s pelvic floor muscle strength and urinary and anal incontinence after childbirth: a cross-sectional study [PDF]
, 2017 OBJECTIVE To analyse pelvic floor muscle strength (PFMS) and urinary and anal incontinence (UI and AI) in the postpartum period. METHOD Cross-sectional study carried out with women in their first seven months after child birth.
Abrams P +35 more
core +3 more sources
Galician Medical Journal, 2017 We represent the results of the combined method of treatment and prevention of miscarriage in women with a multiple pregnancy and a high risk of the threat of termination the pregnancy because of using the obstetric unloading pessaries, combined with ...
Iryna Nikitina +3 more
doaj +1 more source